A Message from the Editor-in-Chief – Justin Budz

On behalf of the Rho Chi Post, we are excited to announce our Inaugural LEADS Initiative Edition of the Rho Chi Post Newsletter. The LEADS Initiative is a pilot program, in collaboration with the Rho Chi Honor Society – Beta Delta Chapter, looking to promote the professional development of younger pharmacy students by pairing them with students in their professional years. Of the many aspects that the LEADS Initiative offers, my favorite involves the opportunity to earn a national publication in the Rho Chi Post Newsletter. This Issue of the Rho Chi Post showcases the hard work of our mentor-mentee pairs. Each pair of students researched topics in pharmacy and healthcare and worked with the Rho Chi Post Editorial Team to develop their final publications. This Inaugural Issue also holds a collaborative publication between myself and the incoming 2023-2024 Editor-in-Chief, Isabelle Lim. For students interested in the LEADS Initiative for the upcoming 2023-2024 academic school year, turn to the “About the LEADS Initiative” section of this newsletter to learn more about the program and how to get involved as a mentor or mentee!

eMAR

Recent Posts

Oxidative Stress and Its Impact on Vitiligo

By: Zurriya Faran, PharmD Candidate c/o 2031 The visible loss of skin pigmentation often indicates…

2 months ago

Thiamine Metabolic Dysfunction Syndrome: Overview, importance, MOA, and treatment

By: Archana Murugan, PharmD candidate c/o 2029 Overview             Thiamine metabolic dysfunction syndrome (TMDS) refers…

2 months ago

Updated Guidelines for the Treatment of Multidrug and Rifampin-Resistant TB and Promising New Anti-TB Drugs in Phase 2/3 Trials

By: Kevin Lee, PharmD Candidate c/o 2028, Angela Yin, PharmD Candidate c/o 2028             The…

2 months ago

Sixth Year Perspective: Interview with Ariella Zadrima, PharmD Candidate, c/o 2026

By: Aymon Choudhury, PharmD Candidate c/o 2027 APPE questions: How did your APPE rotations shape…

2 months ago

Foundayo: The New Drug in the GLP-1 market

By: Sariah Grant, PharmD Candidate c/o 2027             The rise of glucagon-like peptide -1 receptor…

2 months ago

Should All Drugs be OTC? Risks and Consequences of the FDA Commissioner Statement

By: Amanda Kastel, PharmD Candidate c/o 2027 In February 2026, FDA Commissioner Marty Makary stated…

2 months ago